News Summary: Amgen nabs deCODE Genetics for $415M

Published



AMGEN DEAL: Biotech pioneer Amgen will pay $415 million for Iceland’s deCODE Genetics, a leader in using genetic information to find disease risk factors and treatment targets.

THE RATIONALE: Amgen, the world’s largest biotech company by revenue, wants to use deCODE’s huge database of genetic and medical information on Iceland’s population to find targets for diseases linked to genes.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.